Population-level impact of pre-exposure prophylaxis for HIV in New South Wales, Australia

March 15, 2019

Share article

HIV pre-exposure prophylaxis (PrEP) has been shown to be highly effective in men who have sex with men (MSM) at an individual level but its population-level impact is not clear. The authors were interested in whether rapid, targeted and high-coverage roll-out of PrEP in an MSM epidemic would reduce HIV incidence in the cohort prescribed PrEP and state-wide in New South Wales (NSW), Australia. They performed an implementation cohort study of daily co-formulated tenofovir disoproxil fumarate and emtricitabine as HIV PrEP. 3700 high-risk MSM were recruited, with a median age was 36 years. 83% of participants attended a visit at 12 months or later. Over 4100 person-years, two men became infected with HIV (incidence 0·048 per 100 person-years). Both had been non-adherent to PrEP. HIV diagnoses in MSM in NSW decreased from 295 in the 12 months prior to PrEP roll-out to 221 in the 12 months after (relative risk reduction [RRR] 25·1%, 95%CI 10·5-37·4%). There was also a decline in both recent HIV infections (from 149 to 102, RRR 31·5%, 95%CI 11·3–47·3%) and in other HIV diagnoses (from 146 to 119, RRR 18·5%, 95%CI -4·5 to 36·6%). Therefore PrEP implementation is associated with a rapid decline in HIV diagnoses in New South Wales, and was greatest for recent infections.

Read more here

Grulich AE, Guy R, Amin J, Jin F, Selvey C, et al. ISSN: Lancet HIV; 5(11): e629-e637


Added: March 15, 2019